These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8985051)

  • 1. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis.
    Taylor JS; Langston JW; Reddick WE; Kingsley PB; Ogg RJ; Pui MH; Kun LE; Jenkins JJ; Chen G; Ochs JJ; Sanford RA; Heideman RL
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1251-61. PubMed ID: 8985051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Wald LL; Nelson SJ; Day MR; Noworolski SE; Henry RG; Huhn SL; Chang S; Prados MD; Sneed PK; Larson DA; Wara WM; McDermott M; Dillon WP; Gutin PH; Vigneron DB
    J Neurosurg; 1997 Oct; 87(4):525-34. PubMed ID: 9322843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy.
    Kamada K; Houkin K; Abe H; Sawamura Y; Kashiwaba T
    Neurol Med Chir (Tokyo); 1997 Mar; 37(3):250-6. PubMed ID: 9095625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.
    Preul MC; Leblanc R; Caramanos Z; Kasrai R; Narayanan S; Arnold DL
    Can J Neurol Sci; 1998 Feb; 25(1):13-22. PubMed ID: 9532276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
    Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part II: Clinical analysis.
    Byrd SE; Tomita T; Palka PS; Darling CF; Norfray JP; Fan J
    J Natl Med Assoc; 1996 Nov; 88(11):717-23. PubMed ID: 8961691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
    Isobe T; Akutsu H; Yamamoto T; Shiigai M; Masumoto T; Nakai K; Takano S; Anno I; Matsumura A
    No Shinkei Geka; 2011 May; 39(5):485-90. PubMed ID: 21512199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
    Ando K; Ishikura R; Nagami Y; Morikawa T; Takada Y; Ikeda J; Nakao N; Matsumoto T; Arita N
    Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Mar; 64(3):121-6. PubMed ID: 15148787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-Enhanced Perfusion MR Imaging to Differentiate Between Recurrent/Residual Brain Neoplasms and Radiation Necrosis.
    Metaweh NAK; Azab AO; El Basmy AAH; Mashhour KN; El Mahdy WM
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):941-948. PubMed ID: 29693348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors.
    Lin A; Bluml S; Mamelak AN
    J Neurooncol; 1999; 45(1):69-81. PubMed ID: 10728912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
    Chuang MT; Liu YS; Tsai YS; Chen YC; Wang CK
    PLoS One; 2016; 11(1):e0141438. PubMed ID: 26741961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the utility of
    Crain ID; Elias PS; Chapple K; Scheck AC; Karis JP; Preul MC
    J Neurooncol; 2017 May; 133(1):97-105. PubMed ID: 28555423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis.
    Rock JP; Scarpace L; Hearshen D; Gutierrez J; Fisher JL; Rosenblum M; Mikkelsen T
    Neurosurgery; 2004 May; 54(5):1111-7; discussion 1117-9. PubMed ID: 15113465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
    J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
    Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.